Department of Pulmonary and Critical Care Medicine, The Fifth Affiliated Hospital of Sun Yat-sen University, 52 East Meihua Rd, Zhuhai City, 519000, China.
Guangdong Provincial Key Laboratory of Biomedical Imaging, The Fifth Affiliated Hospital of Sun Yat-sen University, 52 East Meihua Rd, Zhuhai City, 519000, China.
Respir Res. 2020 Jun 29;21(1):163. doi: 10.1186/s12931-020-01429-6.
This study investigated the influence of Coronavirus Disease 2019 (COVID-19) on lung function in early convalescence phase.
A retrospective study of COVID-19 patients at the Fifth Affiliated Hospital of Sun Yat-sen University were conducted, with serial assessments including lung volumes (TLC), spirometry (FVC, FEV1), lung diffusing capacity for carbon monoxide (DLCO),respiratory muscle strength, 6-min walking distance (6MWD) and high resolution CT being collected at 30 days after discharged.
Fifty-seven patients completed the serial assessments. There were 40 non-severe cases and 17 severe cases. Thirty-one patients (54.3%) had abnormal CT findings. Abnormalities were detected in the pulmonary function tests in 43 (75.4%) of the patients. Six (10.5%), 5(8.7%), 25(43.8%) 7(12.3%), and 30 (52.6%) patients had FVC, FEV1, FEV1/FVC ratio, TLC, and DLCO values less than 80% of predicted values, respectively. 28 (49.1%) and 13 (22.8%) patients had PImax and PEmax values less than 80% of the corresponding predicted values. Compared with non-severe cases, severe patients showed higher incidence of DLCO impairment (75.6%vs42.5%, p = 0.019), higher lung total severity score (TSS) and R20, and significantly lower percentage of predicted TLC and 6MWD. No significant correlation between TSS and pulmonary function parameters was found during follow-up visit.
Impaired diffusing-capacity, lower respiratory muscle strength, and lung imaging abnormalities were detected in more than half of the COVID-19 patients in early convalescence phase. Compared with non-severe cases, severe patients had a higher incidence of DLCO impairment and encountered more TLC decrease and 6MWD decline.
本研究旨在探讨 2019 年冠状病毒病(COVID-19)对早期康复阶段肺功能的影响。
对中山大学附属第五医院的 COVID-19 患者进行回顾性研究,在出院后 30 天内连续评估肺容积(TLC)、肺活量(FVC、FEV1)、肺一氧化碳弥散量(DLCO)、呼吸肌力量、6 分钟步行距离(6MWD)和高分辨率 CT。
57 例患者完成了连续评估。其中非重症 40 例,重症 17 例。31 例(54.3%)患者 CT 检查异常。43 例(75.4%)患者肺功能检查异常。分别有 6(10.5%)、5(8.7%)、25(43.8%)、7(12.3%)和 30(52.6%)例患者的 FVC、FEV1、FEV1/FVC 比值、TLC 和 DLCO 值低于预测值的 80%。28 例(49.1%)和 13 例(22.8%)患者的 PImax 和 PEmax 值低于相应预测值的 80%。与非重症患者相比,重症患者的 DLCO 损害发生率更高(75.6%对 42.5%,p=0.019),TSS 和 R20 更高,预测 TLC 和 6MWD 的百分比明显更低。在随访过程中,TSS 与肺功能参数之间无明显相关性。
在 COVID-19 患者的早期康复阶段,超过一半的患者存在弥散能力受损、呼吸肌力量下降和肺部影像学异常。与非重症患者相比,重症患者的 DLCO 损害发生率更高,TLC 下降和 6MWD 下降更为明显。